A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh. by Shyam Sundar, Krishna Pandey, Dinesh Mondal, Major Madhukar, Roshan Kamal Topno, Ashish Kumar, Vinod Kumar, Deepak Kumar Verma, Jaya Chakravarty, Rahul Chaubey, Poonam Kumari, Md Utba Rashid, Shomik Maruf, Prakash Ghosh, Sheeraz Raja, Joelle Rode, Margriet den Boer, Pradeep Das, Jorge Alvar, Suman Rijal, Fabiana Alves

Connect to this object online.